1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFunds research on transporters in key biological barriers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Nonprofits, for-profit organizations, state and local governments, institutions of higher education, and tribal organizations. Confirm the full requirements in the official notice before applying.
The current listing shows up to $3,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Elucidation and Validation of the Role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier are due October 20, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Elucidation and Validation of the Role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV) is sponsored by National Institutes of Health. Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV) is a forecasted funding opportunity on Grants.gov from National Institutes of Health. Fiscal Year: 2027. Assistance Listing Number(s): 93.855. <p><span style="color: rgb(51, 51, 51);">The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by soliciting applications to support Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV (PLWH) and Hepatitis B Virus (HBV). This program will focus on: elucidating mechanisms of persistence and pathogenesis; discovering and developing clinically relevant biomarkers; discovering and/or validating host and/or new viral drug ...
Research Program on Autism Spectrum Disorders is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This program supports research designed to elucidate the characterization, pathophysiology, treatment, and outcomes of autism and related disorders. Of particular interest are studies that will lead to enhanced phenotyping, a better understanding of mechanisms and underlying neurobiology, validated measures for use as stratification tools or to assess outcomes in response to treatment, and novel treatments and intervention strategies. While primarily research-focused, it could potentially fund projects with a strong research component related to adult day programs or inclusive recreation if they contribute to understanding or improving outcomes.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH. This program invites research applications to elucidate age-related mechanisms that influence the development and/or course of osteoporosis and to develop strategies aimed at preventing or lessening the burden of osteoporosis-related fractures in older individuals. It seeks basic and clinical research to identify and evaluate the effects of age on factors related to bone quality and/or strategies to modify the impact of these factors on skeletal fragility and increased fracture susceptibility. An example grant funded under this program focuses on validating biochemical and imaging biomarkers as predictors of incident fragility fracture in people with Duchenne muscular dystrophy.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article